Free Trial

Concentrix (NASDAQ:CNXC) Updates Q2 Earnings Guidance

Concentrix logo with Business Services background
Remove Ads

Concentrix (NASDAQ:CNXC - Get Free Report) issued an update on its second quarter earnings guidance on Wednesday morning. The company provided EPS guidance of $2.69-2.80 for the period, compared to the consensus EPS estimate of $2.79. The company issued revenue guidance of $2.37-2.39 billion, compared to the consensus revenue estimate of $2.36 billion. Concentrix also updated its FY 2025 guidance to 11.180-11.770 EPS.

Wall Street Analyst Weigh In

CNXC has been the topic of a number of recent analyst reports. Canaccord Genuity Group decreased their price objective on shares of Concentrix from $100.00 to $80.00 and set a "buy" rating on the stock in a research note on Thursday, January 16th. Barrington Research lowered their price target on Concentrix from $70.00 to $54.00 and set an "outperform" rating for the company in a report on Monday, March 24th. Finally, Bank of America raised their price objective on Concentrix from $58.00 to $59.00 and gave the company a "neutral" rating in a research note on Thursday. One analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the company's stock. Based on data from MarketBeat, Concentrix has a consensus rating of "Buy" and an average target price of $69.60.

Get Our Latest Analysis on CNXC

Concentrix Price Performance

Shares of CNXC traded down $8.09 during trading hours on Friday, reaching $56.95. The stock had a trading volume of 3,240,808 shares, compared to its average volume of 671,740. The stock has a market capitalization of $3.66 billion, a PE ratio of 15.35, a PEG ratio of 0.63 and a beta of 0.69. Concentrix has a 12 month low of $36.28 and a 12 month high of $77.00. The company has a debt-to-equity ratio of 1.17, a quick ratio of 1.42 and a current ratio of 1.42. The company's 50-day moving average is $48.06 and its two-hundred day moving average is $47.60.

Remove Ads

Concentrix (NASDAQ:CNXC - Get Free Report) last announced its quarterly earnings results on Wednesday, March 26th. The company reported $2.79 EPS for the quarter, beating analysts' consensus estimates of $2.58 by $0.21. Concentrix had a return on equity of 16.67% and a net margin of 2.61%. The firm had revenue of $2.37 billion for the quarter, compared to analyst estimates of $2.37 billion. During the same period last year, the firm posted $2.57 earnings per share. The business's revenue for the quarter was down 1.3% on a year-over-year basis. Research analysts expect that Concentrix will post 10.11 EPS for the current year.

Concentrix Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, May 6th. Shareholders of record on Friday, April 25th will be given a $0.3328 dividend. This represents a $1.33 annualized dividend and a yield of 2.34%. The ex-dividend date of this dividend is Friday, April 25th. Concentrix's dividend payout ratio (DPR) is currently 35.85%.

Insider Activity

In other news, EVP Cormac J. Twomey sold 500 shares of the firm's stock in a transaction dated Wednesday, January 29th. The stock was sold at an average price of $55.60, for a total transaction of $27,800.00. Following the completion of the transaction, the executive vice president now directly owns 41,111 shares in the company, valued at $2,285,771.60. This trade represents a 1.20 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 3.20% of the company's stock.

About Concentrix

(Get Free Report)

Concentrix Corporation engages in the provision of technology-infused customer experience (CX) solutions worldwide. The company provides CX process optimization, technology innovation, front- and back-office automation, analytics, and business transformation services, across various channels of communication, such as voice, chat, email, social media, asynchronous messaging, and custom applications.

Featured Articles

Should You Invest $1,000 in Concentrix Right Now?

Before you consider Concentrix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Concentrix wasn't on the list.

While Concentrix currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

 5 Stocks to BUY NOW in April 2025

5 Stocks to BUY NOW in April 2025

March came in like a lion, and investors are hoping April brings a gentler outlook.

Recent Videos

5 International Stocks to Escape U.S. Market Volatility
MicroStrategy’s Bold Bitcoin Bet: Genius Move or Dangerous Gamble?
5 Big Reasons the S&P 500 Could Soar in 2025

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads